AAAAAA

   
Results: 1-23 |
Results: 23
Vascular viewpoint: an evidence-based approach to vascular medicine
Authors: Creager, MA Anand, SS
Citation: Ma. Creager et Ss. Anand, Vascular viewpoint: an evidence-based approach to vascular medicine, VASC MED, 6(1), 2001, pp. 1-1
Vascular viewpoint
Authors: Anand, SS
Citation: Ss. Anand, Vascular viewpoint, VASC MED, 6(1), 2001, pp. 61-61
Mechanism of action and pharmacology of unfractionated heparin
Authors: Hirsh, J Anand, SS Halperin, JL Fuster, V
Citation: J. Hirsh et al., Mechanism of action and pharmacology of unfractionated heparin, ART THROM V, 21(7), 2001, pp. 1094-1096
Guidelines as rationing tools: a qualitative analysis of psychosocial patient selection criteria for cardiac procedures
Authors: Giacomini, MK Cook, DJ Streiner, DL Anand, SS
Citation: Mk. Giacomini et al., Guidelines as rationing tools: a qualitative analysis of psychosocial patient selection criteria for cardiac procedures, CAN MED A J, 164(5), 2001, pp. 634-640
Risk factors, atherosclerosis, and cardiovascular disease among Aboriginalpeople in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP)
Authors: Anand, SS Yusuf, S Jacobs, R Davis, AD Yi, QL Gerstein, H Montague, PA Lonn, E
Citation: Ss. Anand et al., Risk factors, atherosclerosis, and cardiovascular disease among Aboriginalpeople in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP), LANCET, 358(9288), 2001, pp. 1147-1153
On prognostic models, artificial intelligence and censored observations
Authors: Anand, SS Hamilton, PW Hughes, JG Bell, DA
Citation: Ss. Anand et al., On prognostic models, artificial intelligence and censored observations, METH INF M, 40(1), 2001, pp. 18-24
Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
Authors: Hirsh, J Warkentin, TE Shaughnessy, SG Anand, SS Halperin, JL Raschke, R Granger, C Ohman, EM Dalen, JE
Citation: J. Hirsh et al., Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety, CHEST, 119(1), 2001, pp. 64S-94S
Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation - Organization to assess strategies for ischemic syndromes (OASIS-2) study
Authors: Eikelboom, JW Anand, SS Mehta, SR Weitz, JI Yi, CL Yusuf, S
Citation: Jw. Eikelboom et al., Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation - Organization to assess strategies for ischemic syndromes (OASIS-2) study, CIRCULATION, 103(5), 2001, pp. 643-650
Guide to anticoagulant therapy: Heparin a statement for healthcare professionals from the American Heart Association
Authors: Hirsh, J Anand, SS Halperin, JL Fuster, V
Citation: J. Hirsh et al., Guide to anticoagulant therapy: Heparin a statement for healthcare professionals from the American Heart Association, CIRCULATION, 103(24), 2001, pp. 2994-3018
Treatment of acute coronary syndromes: which heparin and for how long?
Authors: Anand, SS Hirsh, J
Citation: Ss. Anand et J. Hirsh, Treatment of acute coronary syndromes: which heparin and for how long?, CHALLENGES IN ACUTE CORONARY SYNDROMES, 2001, pp. 203-214
Using practice guidelines to allocate medical technologies - An ethics framework
Authors: Giacomini, MK Cook, DJ Streiner, DL Anand, SS
Citation: Mk. Giacomini et al., Using practice guidelines to allocate medical technologies - An ethics framework, INT J TE A, 16(4), 2000, pp. 987-1002
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
Authors: Anand, SS Yusuf, S Vuksan, V Devanesen, S Teo, KK Montague, PA Kelemen, L Yi, CL Lonn, E Gerstein, H Hegele, RA McQueen, M
Citation: Ss. Anand et al., Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE), LANCET, 356(9226), 2000, pp. 279-284
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without St elevation: a meta-analysis
Authors: Eikelboom, JW Anand, SS Malmberg, K Weitz, JI Ginsberg, JS Yusuf, S
Citation: Jw. Eikelboom et al., Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without St elevation: a meta-analysis, LANCET, 355(9219), 2000, pp. 1936-1942
Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke
Authors: Eikelboom, JW Hankey, GJ Anand, SS Lofthouse, E Staples, N Baker, RI
Citation: Jw. Eikelboom et al., Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke, STROKE, 31(5), 2000, pp. 1069-1075
Personalization on the net using Web mining
Authors: Mulvenna, MD Anand, SS Buchner, AG
Citation: Md. Mulvenna et al., Personalization on the net using Web mining, COMM ACM, 43(8), 2000, pp. 123-125
Towards the handling of uncertainty in knowledge discovery in databases
Authors: Anand, SS Hughes, JG Bell, DA
Citation: Ss. Anand et al., Towards the handling of uncertainty in knowledge discovery in databases, STUD FUZZ S, 39, 2000, pp. 305-333
An evaluation of intelligent prognostic systems for colorectal cancer
Authors: Anand, SS Smith, AE Hamilton, PW Anand, JS Hughes, JG Bartels, PH
Citation: Ss. Anand et al., An evaluation of intelligent prognostic systems for colorectal cancer, ARTIF INT M, 15(2), 1999, pp. 193-214
Low rates of preventive practices in patients with peripheral vascular disease
Authors: Anand, SS Kundi, A Eikelboom, J Yusuf, S
Citation: Ss. Anand et al., Low rates of preventive practices in patients with peripheral vascular disease, CAN J CARD, 15(11), 1999, pp. 1259-1263
Oral anticoagulant therapy in patients with coronary artery disease: A meta-analysis
Authors: Anand, SS Yusuf, S
Citation: Ss. Anand et S. Yusuf, Oral anticoagulant therapy in patients with coronary artery disease: A meta-analysis, J AM MED A, 282(21), 1999, pp. 2058-2067
Recurrent venous thrombosis and heparin therapy - An evaluation of the importance of early activated partial thromboplastin times
Authors: Anand, SS Bates, S Ginsberg, JS Levine, M Buller, H Prins, M Haley, S Kearon, C Hirsh, J GEnt, M
Citation: Ss. Anand et al., Recurrent venous thrombosis and heparin therapy - An evaluation of the importance of early activated partial thromboplastin times, ARCH IN MED, 159(17), 1999, pp. 2029-2032
The Organization to Assess Strategies for Ischemic Syndromes (OASIS) pilotstudy: Evaluation of acute and long-term therapies for patients with acutecoronary syndromes without ST elevation
Authors: Anand, SS
Citation: Ss. Anand, The Organization to Assess Strategies for Ischemic Syndromes (OASIS) pilotstudy: Evaluation of acute and long-term therapies for patients with acutecoronary syndromes without ST elevation, AM J CARD, 84(5A), 1999, pp. 13M-19M
The study of health assessment and risk in ethnic groups (SHARE): Rationale and design
Authors: Anand, SS Yusuf, S Vuksan, V Devanesen, S Montague, P Kelemen, L Bosch, J Sigouin, C Teo, KK Lonn, E Gerstein, HC Hegele, RA McQueen, M
Citation: Ss. Anand et al., The study of health assessment and risk in ethnic groups (SHARE): Rationale and design, CAN J CARD, 14(11), 1998, pp. 1349-1357
Risk stratification for symptomatic atherosclerosis
Authors: Anand, SS Yusuf, S
Citation: Ss. Anand et S. Yusuf, Risk stratification for symptomatic atherosclerosis, CRITICAL DECISIONS IN THROMBOSIS AND HEMOSTASIS, 1998, pp. 179-189
Risultati: 1-23 |